Detalhe da pesquisa
1.
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer.
Mol Cancer
; 23(1): 17, 2024 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38229082
2.
Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin.
Front Cell Dev Biol
; 10: 1014798, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36544904
3.
Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance.
Genome Med
; 14(1): 120, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36266692